The future of medical isotope supply - 2017 status update

In April 2014, the NEA analysed likely future market demand and projected production capacity for ⁹⁹Mo. This research identified a period beyond 2016 of increased risk when further supply disruption could result from a number of ageing supply chain participants ending their activities. The analysis also examined the likely deployment of potential new capacity and confirmed that the introduction of new capacity would be vital to ensure security of supply. Concerns were expressed at the time about the possibility of potential new facilities experiencing project delays. The overall conclusion was that 2017 would represent the start of a period of particular risk, with a likely nadir in production capacity as a result of planned facility closures and project delays. In 2017, the NEA is pleased to report that market participants have reacted positively to the concerns identified in 2014